| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |